Mihir D. Parikh
Pfizer (United States)(US)
Publications by Year
Research Areas
Click Chemistry and Applications, Cytokine Signaling Pathways and Interactions, Crystallization and Solubility Studies, X-ray Diffraction in Crystallography, T-cell and B-cell Immunology
Most-Cited Works
- → Rational Targeting of Active-Site Tyrosine Residues Using Sulfonyl Fluoride Probes(2015)191 cited
- → Identification of N-{cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for the Treatment of Autoimmune Diseases(2018)163 cited
- → Identification of a Chemical Probe for Family VIII Bromodomains through Optimization of a Fragment Hit(2016)108 cited
- → Chemoselective Preparation of Clickable Aryl Sulfonyl Fluoride Monomers: A Toolbox of Highly Functionalized Intermediates for Chemical Biology Probe Synthesis(2016)55 cited
- → Porphyrins with exocyclic rings. Part 19: Efficient syntheses of phenanthrolinoporphyrins(2005)50 cited
- → Benzothiophene inhibitors of MK2. Part 2: Improvements in kinase selectivity and cell potency(2009)46 cited
- → PF-07059013: A Noncovalent Modulator of Hemoglobin for Treatment of Sickle Cell Disease(2020)41 cited
- → Structure-based drug design enables conversion of a DFG-in binding CSF-1R kinase inhibitor to a DFG-out binding mode(2010)35 cited
- → Aminopyrazole Carboxamide Bruton’s Tyrosine Kinase Inhibitors. Irreversible to Reversible Covalent Reactive Group Tuning(2018)27 cited
- → Selectively targeting an inactive conformation of interleukin-2-inducible T-cell kinase by allosteric inhibitors(2014)24 cited